Rallybio (RLYB) Short Interest Ratio & Short Volume → New trading system called MSFT, NVDA & MSFT (From WealthPress) (Ad) Free RLYB Stock Alerts $1.58 +0.12 (+7.82%) (As of 11:28 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Rallybio Short Interest DataCurrent Short Interest1,740,000 sharesPrevious Short Interest1,960,000 sharesChange Vs. Previous Month-11.22%Dollar Volume Sold Short$3.32 millionShort Interest Ratio1.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares41,450,000 sharesFloat Size21,530,000 sharesShort Percent of Float8.08%Today's Trading Volume91,796 sharesAverage Trading Volume1,065,160 sharesToday's Volume Vs. Average9% Short Selling Rallybio ? Sign up to receive the latest short interest report for Rallybio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRLYB Short Interest Over TimeRLYB Days to Cover Over TimeRLYB Percentage of Float Shorted Over Time Ad Daily Strike Alliance🚀 Tap into this explosive trade opportunity asapI learned about these explosive stocks during my two decades on Wall Street… And used them to help grow my old hedge fund from just a few million to over $700 million dollars*. So it’s safe to say… these bad boys work. What’s the secret behind these special trades? Well, right now, I’m going public with the unique strategy behind these “Calendar Stocks”…Go here to see how you can exploit my next “Calendar Stock”. Rallybio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,740,000 shares $3.32 million -11.2%8.1%1.1 $1.91 4/30/20241,960,000 shares $3.76 million -33.8%9.7%1.2 $1.92 4/15/20242,960,000 shares $5.42 million +126.0%17.2%1.9 $1.83 3/31/20241,310,000 shares $2.42 million +2.3%7.6%6.2 $1.85 3/15/20241,280,000 shares $2.07 million +6.7%7.4%5.7 $1.62 2/29/20241,200,000 shares $2.79 million +11.1%7.0%5.2 $2.33 Get the Latest News and Ratings for RLYB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rallybio and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,080,000 shares $2.01 million +43.4%6.3%4.8 $1.86 1/31/2024753,400 shares $1.02 million +1.2%4.4%3.5 $1.35 1/15/2024744,600 shares $1.42 million +9.9%4.3%5.1 $1.91 12/31/2023677,600 shares $1.62 million -62.6%3.9%5.5 $2.39 12/15/20231,810,000 shares $5.50 million -14.6%10.7%16.8 $3.04 11/30/20232,120,000 shares $4.05 million -0.5%12.6%24.7 $1.91 11/15/20232,130,000 shares $4.97 million +0.5%12.6%34.2 $2.34 10/31/20232,120,000 shares $8.90 million +119.3%12.6%49 $4.20 10/15/2023966,800 shares $3.56 million -4.3%5.7%24.6 $3.68 9/30/20231,010,000 shares $3.40 million +1.0%6.0%24.3 $3.37 9/15/20231,000,000 shares $4.93 million No Change5.9%12.9 $4.93 8/31/20231,000,000 shares $5.32 million -4.8%5.9%11.5 $5.32 8/15/20231,050,000 shares $6.29 million -1.9%6.2%10.5 $5.99 7/31/20231,070,000 shares $6.40 million -5.3%6.4%11 $5.98 7/15/20231,130,000 shares $6.16 million +4.6%6.8%11.9 $5.45 6/30/20231,080,000 shares $6.11 million +41.8%6.8%11.4 $5.66 6/15/2023761,900 shares $5.62 million -18.6%4.8%8.3 $7.37 5/31/2023936,300 shares $6.70 million -0.1%5.8%15.7 $7.16 5/15/2023936,800 shares $5.10 million -0.1%5.8%16.8 $5.44 4/30/2023938,100 shares $5.06 million +1.5%5.8%16.5 $5.39 4/15/2023924,000 shares $3.98 million +1.0%5.7%14.4 $4.31 3/31/2023914,800 shares $5.22 million +3.3%5.9%14 $5.71 3/15/2023885,800 shares $4.43 million +11.4%5.7%13.5 $5.00 2/28/2023795,400 shares $6.26 million +0.5%5.2%9.3 $7.87 2/15/2023791,200 shares $5.44 million +8.3%5.3%9.1 $6.87 1/31/2023730,300 shares $5.07 million +2.5%4.8%6.3 $6.94 1/15/2023712,800 shares $4.40 million -7.1%4.5%6 $6.17 12/30/2022767,600 shares $5.04 million -0.3%4.9%6.6 $6.57 12/15/2022769,800 shares $5.40 million +1.0%4.4%6.5 $7.02 11/30/2022762,400 shares $4.39 million +0.6%5.3%7.6 $5.76 11/15/2022757,600 shares $4.42 million -1.1%5.2%8 $5.84 10/31/2022766,200 shares $7.32 million -0.4%6.1%13.5 $9.56 10/15/2022769,200 shares $6.69 million +1.3%6.1%14.3 $8.70 9/30/2022759,400 shares $10.99 million +19.0%6.1%15.3 $14.47New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! 9/15/2022638,300 shares $8.62 million -5.1%5.1%11.3 $13.51 8/31/2022672,700 shares $7.43 million -1.4%5.4%12.4 $11.05 8/15/2022681,900 shares $8.83 million -1.1%5.4%8.2 $12.95 7/31/2022689,500 shares $6.43 million -4.4%5.3%8.1 $9.33 7/15/2022720,900 shares $6.61 million +2.3%5.5%8.3 $9.17 6/30/2022704,500 shares $5.32 million +1.0%5.4%7.4 $7.55 6/15/2022697,600 shares $4.88 million -3.2%5.4%6.6 $7.00 5/31/2022720,900 shares $9.80 million +3.5%5.6%5.3 $13.60 5/15/2022696,700 shares $7.64 million -0.4%5.5%5.5 $10.97 4/30/2022699,400 shares $6.97 million -0.9%5.3%5.4 $9.96 4/15/2022705,500 shares $6.37 million +11.8%5.3%5.4 $9.03 3/31/2022631,000 shares $4.40 million +41.3%4.8%5.1 $6.98 3/15/2022446,700 shares $3.86 million +1.8%3.4%3.8 $8.64 2/28/2022438,900 shares $4.82 million -1.7%3.3%5.9 $10.99 2/15/2022446,600 shares $5.76 million -17.8%3.4%7 $12.90 1/31/2022543,200 shares $6.61 million +2.6%3.9%9.5 $12.16 1/15/2022529,600 shares $4.70 million +10.7%3.9%11.1 $8.87 12/31/2021478,400 shares $4.56 million +12.0%3.5%9.4 $9.54 12/15/2021427,300 shares $4.37 million +8.5%3.1%8 $10.22 11/30/2021393,700 shares $5.07 million -3.6%2.8%5.4 $12.87 11/15/2021408,300 shares $5.68 million -10.4%2.9%4.9 $13.92 10/29/2021455,600 shares $8.13 million +24.6%3.3%4.9 $17.85 10/15/2021365,800 shares $5.68 million +34.7%2.6%2.5 $15.52 9/30/2021271,600 shares $4.77 million +90.5%2.0%1.6 $17.58 9/15/2021142,600 shares $1.82 million +145.9%1.0%0.8 $12.77 8/31/202158,000 shares $762,700.00 -33.9%0.4%0.3 $13.15 8/13/202187,800 shares $1.50 million No Change0.7%0.4 $17.10 RLYB Short Interest - Frequently Asked Questions What is Rallybio's current short interest? Short interest is the volume of Rallybio shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 1,740,000 shares of RLYB short. 8.08% of Rallybio's shares are currently sold short. Learn More on Rallybio's current short interest. What is a good short interest ratio for Rallybio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLYB shares currently have a short interest ratio of 1.0. Learn More on Rallybio's short interest ratio. What is a good short interest percentage for Rallybio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.08% of Rallybio's floating shares are currently sold short. Is Rallybio's short interest increasing or decreasing? Rallybio saw a decrease in short interest in May. As of May 15th, there was short interest totaling 1,740,000 shares, a decrease of 11.2% from the previous total of 1,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Rallybio's float size? Rallybio currently has issued a total of 41,450,000 shares. Some of Rallybio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rallybio currently has a public float of 21,530,000 shares. How does Rallybio's short interest compare to its competitors? 8.08% of Rallybio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Rallybio: Leap Therapeutics, Inc. (5.29%), CytomX Therapeutics, Inc. (11.23%), Cardiff Oncology, Inc. (10.33%), Enanta Pharmaceuticals, Inc. (14.23%), Immutep Limited (4.24%), Emergent BioSolutions Inc. (11.97%), Foghorn Therapeutics Inc. (5.35%), Acrivon Therapeutics, Inc. (4.79%), XBiotech Inc. (3.65%), Design Therapeutics, Inc. (8.59%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Rallybio stock? Short selling RLYB is an investing strategy that aims to generate trading profit from Rallybio as its price is falling. RLYB shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rallybio? A short squeeze for Rallybio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLYB, which in turn drives the price of the stock up even further. How often is Rallybio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLYB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: LPTX Short Interest Data CTMX Short Interest Data CRDF Short Interest Data ENTA Short Interest Data IMMP Short Interest Data EBS Short Interest Data FHTX Short Interest Data ACRV Short Interest Data XBIT Short Interest Data DSGN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLYB) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyBUY ALERT: Tiny tech play partners with US governmentStansberry ResearchGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rallybio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.